| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 2,531,100 | 2,484,100 | 2,255,100 | 2,646,300 | | Cost of Revenue | 1,519,900 | 1,495,800 | 1,368,200 | 1,579,300 | | | Gross Profit | 1,011,200 | 988,300 | 886,900 | 1,067,000 | | | Operating Expenses | | Research Development | 60,500 | 58,100 | 58,200 | 60,900 | | Selling General and Administrative | 662,100 | 660,900 | 625,000 | 663,100 | | Non Recurring | 13,100 | 10,300 | 13,600 | 20,500 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 275,500 | 259,000 | 190,100 | 322,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 600 | 2,700 | 7,300 | 3,200 | | Earnings Before Interest And Taxes | 276,100 | 261,700 | 197,400 | 329,100 | | Interest Expense | 29,200 | 29,600 | 30,200 | 28,800 | | Income Before Tax | 246,900 | 232,100 | 167,200 | 300,300 | | Income Tax Expense | 25,700 | 25,200 | 18,300 | 9,600 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 221,200 | 206,900 | 148,900 | 290,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (500) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 221,200 | 206,900 | 148,900 | 290,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $221,200 | $206,900 | $148,900 | $290,200 |
|
0.01% Nasdaq 
0.22%
Income Statement
